First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study.

Autor: Silva MRRD; PhD. Pharmacist and Adjunct Professor, Department of Pharmacy and Nutrition, Universidade Federal do Espírito Santo (UFES), Alegre (ES), Brazil., Santos JBRD; PhD. Pharmacist and Adjunct Professor, Department of Pharmacy and Nutrition, Universidade Federal do Espírito Santo (UFES), Alegre (ES), Brazil., Kakehasi AM; PhD. Physician and Associate Professor, Department of Locomotor System, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil., Almeida AM; PhD. Dentist and Adjunct Professor, Instituto de Pesquisa e Pós-Graduação em Ciências Médicas, Faculdade de Ciências Médicas de Minas Gerais (FCMMG), Belo Horizonte (MG), Brazil., Pimenta PRK; MD. Pharmacist and Researcher Department of Social Pharmacy, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil., Alvares-Teodoro J; PhD. Pharmacist and Adjunct Professor, Department of Social Pharmacy, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil., Acurcio FA; PhD. Physician And Full Professor, Department of Social Pharmacy, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte (MG), Brazil.

Publikováno v: Sao Paulo medical journal = Revista paulista de medicina [Sao Paulo Med J] 2022 Nov-Dec; Vol. 140 (6), pp. 787-797.

Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Autor: da Silva WC; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., de Araujo VE; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; School of Dentistry, Pontifical Catholic University of Minas Gerais, Belo Horizonte, Brazil., Lima EMEA; Mario Penna Institut of Oncology-Minas Gerais, Belo Horizonte, Brazil., Dos Santos JBR; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., Silva MRRD; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., Almeida PHRF; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil., de Assis Acurcio F; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil., Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK. Brian.Godman@strath.ac.uk.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. Brian.Godman@strath.ac.uk.; Health Economics Centre, University of Liverpool Management School, Liverpool, UK. Brian.Godman@strath.ac.uk.; School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, Pretoria, South Africa. Brian.Godman@strath.ac.uk., Kurdi A; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq., Cherchiglia ML; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil., Andrade EIG; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.

Publikováno v: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2018 Dec; Vol. 32 (6), pp. 585-606.

Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus.

Autor: Nishida, Shohei¹ (AUTHOR), Kato, Takehiro^2,3 (AUTHOR), Hayashi, Yuichi⁴ (AUTHOR) y-hayashi@tsuruga-nu.ac.jp, Yamada, Shoya¹ (AUTHOR), Fujii, Hironori¹ (AUTHOR), Yamada, Michi¹ (AUTHOR), Asai, Nao¹ (AUTHOR), Shimizu, Shinya¹ (AUTHOR), Niwa, Takashi¹ (AUTHOR), Iihara, Hirotoshi^1,5 (AUTHOR), Kubota, Sodai^2,3 (AUTHOR), Sakai, Mayu^2,3 (AUTHOR), Takahashi, Yoshihiro^2,3 (AUTHOR), Takao, Ken^2,3 (AUTHOR), Mizuno, Masami^2,3 (AUTHOR), Hirota, Takuo^2,3 (AUTHOR), Kobayashi, Ryo^1,6 (AUTHOR), Horikawa, Yukio^2,3,7 (AUTHOR), Yabe, Daisuke^2,3,8,9,10 (AUTHOR), Suzuki, Akio^1,6 (AUTHOR) akio@gifu-u.ac.jp

Publikováno v: Journal of Diabetes Investigation. Oct2023, Vol. 14 Issue 10, p1202-1208. 7p.

Evaluation of the Relationship Between Polypharmacy and Malnutrition in Diabetic Elderly.

Autor: DATLI YAKARYILMAZ, Funda, ERAYDIN, Ayten

Publikováno v: Namık Kemal Tıp Dergisi; Aug2022, Vol. 10 Issue 2, p199-205, 7p

Bevacizumab‐associated intestinal perforation and perioperative complications in patients receiving bevacizumab.

Autor: Yoshimoto, Toshiaki, Yoshikawa, Kozo, Higashijima, Jun, Miyatani, Tomohiko, Tokunaga, Takuya, Nishi, Masaaki, Takasu, Chie, Kashihara, Hideya, Takehara, Yukako, Shimada, Mitsuo

Publikováno v: Annals of Gastroenterological Surgery; Mar2020, Vol. 4 Issue 2, p151-155, 5p